Psilocybin has been used by humans for centuries, studied by scientists, pushed underground by politics and prohibition, and—more recently—pulled back into the spotlight.
But what do we actually know about it?
Psilocybin: What We Know, What We Don’t, and What We Lost Along the Way explores the remarkable history, science, culture, and modern resurgence of psychedelic mushrooms. From ancient traditions and the first wave of twentieth-century research to the backlash that brought that work to a halt, the book traces how one substance moved from scientific curiosity to cultural controversy—and back again.
Along the way, Ed Chonko examines what modern research is discovering about psilocybin, how the experience changes across different doses, the questions surrounding safety and risk, and the growing interest in its potential relationship to depression, anxiety, addiction, creativity, and personal well-being.
The book also ventures beyond the laboratory, exploring mushroom varieties, cultivation, dosing, the psychedelic experience, microdosing, and the practical questions that often get lost between enthusiastic claims and blanket warnings.
This is neither an argument for psilocybin nor an argument against it. It is an attempt to separate what we know from what we think we know—and to understand what decades of interrupted research may have cost us.
Accessible, skeptical, curious, and grounded in the available evidence, Psilocybin is written for readers who want to understand one of the most fascinating and controversial substances being reconsidered today.
"synopsis" may belong to another edition of this title.
Seller: California Books, Miami, FL, U.S.A.
Condition: New. Seller Inventory # I-9798998382307
Seller: AHA-BUCH GmbH, Einbeck, Germany
Buch. Condition: Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - A DEEPER UNDERSTANDING. A BRIGHTER TOMORROW.Psilocybin is at the center of a scientific, medical, and cultural renaissance. Once dismissed and criminalized, it is now being carefully reexamined for its potential to help with treatment-resistant depression, anxiety, trauma, addiction, and end-of-life distress. But the story is more complex than headlines suggest.In Psilocybin: What We Know, What We Don't, and What We Lost Along the Way, Ed Chonko brings together the latest research, personal experiences, and real-world stories to explore what psilocybin can and cannot do. Drawing on science, history, policy, and lived experience, this book looks beyond the hype to examine the opportunities, risks, and bigger questions facing this remarkable substance-and what it means for mental health, meaning, and the human experience.Inside, you'll find:The history and rediscovery of psilocybin across cultures and medicineCurrent research on mental health, including depression, anxiety, PTSD, addiction, and end-of-life careDosing research and what we know (and don't know) about safety and effectsLegal and regulatory developments in the U.S. and around the worldPotential benefits, risks, and who may be most likely to benefitPerspectives from science, medicine, policy, and lived experienceReflections on healing, meaning, and what it means to be human. Seller Inventory # 9798998382307
Seller: preigu, Osnabrück, Germany
Buch. Condition: Neu. Psilocybin | What We Know, What We Don't, and What We Lost Along the Way | Ed Chonko | Buch | Englisch | 2026 | Second Act House | EAN 9798998382307 | Verantwortliche Person für die EU: Libri GmbH, Europaallee 1, 36244 Bad Hersfeld, gpsr[at]libri[dot]de | Anbieter: preigu Print on Demand. Seller Inventory # 138175156